India's Marksans Pharma rises after UK unit gets marketing authorisation

Marksans Pharma

19/06/2025 05:18

** Shares of Marksans Pharma MARK.NS rise as much as 2.3% to 256 rupees

** Stock on track to snap five-day losing streak
** Pharma co's UK unit gets marketing authorisation from regulator for oxybutynin hydrochloride oral solution to treat overactive bladder symptoms
** MARK last up 1%, cutting YTD losses to 15.7%

 (Reporting by Meenakshi Maidas in Bengaluru)

 ((meenakshi.maidas@thomsonreuters.com;))